Granules India (GRANULES) Share Price falls 2.28% as stock closes at Rs 855.50

Published:   22 September 2026 at 12:49:20 PM IST

Granules India Share Price fell today, with the stock ending at Rs 855.50 after a decline of 2.28%. The move took the counter below its previous close of Rs 875.45 and left the company’s market capitalisation at Rs 23,868.23 crore. In today’s Granules India Share Price Today update, the market has a factual price event to track, but the supplied data does not establish a company-specific catalyst. That makes Granules India Stock News a case of studying the numbers first: the open, the intraday range, the exact fall, and the company’s valuation profile. For readers using Univest, the focus stays on what changed in the share price, how the stock stands versus its own recent levels, and what the available fundamentals say about the present context.

Granules India Share Price Today is also notable because the stock’s intraday low matched the close at Rs 855.50, while the day high of Rs 878.60 stayed close to the open of Rs 875. That keeps the event grounded in observable price action rather than any unverified explanation. Univest tracks this as a stock move worth watching for investors who want a factual read on Granules India Share Price news.

Granules India (GRANULES) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 855.5
Previous Close	Rs 875.45
Today's Move	-Rs 19.95 (-2.28%)
Open	Rs 875
High	Rs 878.6
Low	Rs 855.5
Turnover	Rs 5.4 crore
Market Capitalisation	Rs 23,868.23 crore
Market Cap Category	Large Cap

Granules India Share Price Today shows a clear same-day decline from Rs 875.45 to Rs 855.50, a fall of Rs 19.95 or 2.28%. The stock opened at Rs 875, moved to an intraday high of Rs 878.60, and then slipped to an intraday low of Rs 855.50, which was also the closing price. That sequence tells us the session ended at the day’s weakest printed level, even though the share price briefly traded above the open. The turnover for the session stood at Rs 5.4 crore, which is a factual traded-value figure and should not be read as a cause for the move. In market-cap terms, Granules India sits in the Large Cap category, with a market capitalisation of Rs 23,868.23 crore. For Granules India Share Price analysis, the immediate question is not why the stock moved, but what the exact price path shows: a softer close, a narrow gap between open and high, and a finish at the day’s low. That keeps Granules India Share Price fall in proper context for Granules India Stock News and Granules India Share Price update coverage.

Granules India (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 23,868.23 crore
P/E Ratio	36.05x
P/B Ratio	4.87x
ROE	14.13%
ROCE	15.74%
EPS	Rs 24.28
Book Value Per Share	Rs 179.7
Dividend Yield	0.2%

Granules India Share Price also needs to be read against the company’s fundamentals. The stock trades at a P/E ratio of 36.05 and a P/B ratio of 4.87, while the enterprise-relevant market capitalisation is Rs 23,868.23 crore. Its ROE is 14.13% and ROCE is 15.74%, indicating the return profile currently visible in the supplied data. EPS stands at Rs 24.28, which helps show the earnings attributable to each share, while book value is Rs 179.7 per share. Dividend yield is 0.2%, which reflects the historical payout relative to the current price. These numbers matter because Granules India Share Price Today is not moving in isolation; it is moving against a valuation profile that can be compared with sector peers and benchmark data. In short, the fundamentals give Granules India Stock News a measurable framework: valuation, profitability and shareholder-return metrics are all available, and Univest readers can place the day’s share price fall beside them without assuming a reason that has not been supplied. Granules India Fundamental Analysis therefore remains a key part of Granules India Share Price interpretation.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	36.05x
Benchmark Median P/E	32.62x
Benchmark Average P/E	49.51x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	4.87x
Benchmark Median P/B	3x
Benchmark Average P/B	4.35x
Company ROE	14.13%
Benchmark Median ROE	11.74%
Benchmark Average ROE	10.79%
Company ROCE	15.74%
Benchmark Median ROCE	13.63%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 23,868.23 crore
Benchmark Median Market Cap	Rs 746.45 crore
Benchmark Average Market Cap	Rs 14,202.67 crore

Granules India operates in Healthcare, within the Pharmaceuticals & Drugs industry, and its valuation can be compared with the supplied same-industry benchmark of 200 companies. On that benchmark, the company’s P/E of 36.05 is above the sector median of 32.62 and below the sector average of 49.51. Its P/B of 4.87 is above the sector median of 3.00 and above the average of 4.35. ROE at 14.13% is above the sector median of 11.74% and above the average of 10.79%, while ROCE at 15.74% is above the sector median of 13.63% and above the average of 13.40%. The benchmark market-cap median is Rs 746.45 crore and the average is Rs 14,202.67 crore, so Granules India’s Rs 23,868.23 crore market capitalisation sits above both reference points. In the healthcare industry context, Granules India Share Price today reflects a company valued at a premium to several benchmark measures, but still below the richer multiples seen in some peers. That gives Granules India Share Price fall a valuation backdrop rather than a catalyst story, which is useful for Granules India Stock News readers on Univest.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,40,397.93	37.05	5.18	14.85	19.11
Divi's Laboratories	DIVISLAB	2,48,664.42	85.6	14.18	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,82,738.23	86.64	21.05	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,15,012.19	25.67	4.3	19.69	21.39
Cipla	CIPLA	1,10,793.75	33.19	3.18	11.83	16

Granules India Share Price can be read more clearly beside listed peers in Pharmaceuticals & Drugs. Its P/E of 36.05 is below Divi’s Laboratories at 85.6, Torrent Pharmaceuticals at 86.64 and Laurus Labs at 99.72, but above Zydus Lifesciences at 25.67 and Cipla at 33.19. On P/B, Granules India at 4.87 sits above Zydus Lifesciences at 4.3 and Cipla at 3.18, yet below Divi’s Laboratories at 14.18 and Torrent Pharmaceuticals at 21.05. ROE at 14.13% trails Zydus Lifesciences at 19.69%, Divi’s Laboratories at 16.19%, Torrent Pharmaceuticals at 26.76% and Lupin at 27.11%, but is ahead of Cipla at 11.83%. ROCE at 15.74% is below Lupin at 28.86%, Divi’s Laboratories at 21.51% and Zydus Lifesciences at 21.39%, yet close to Cipla at 16%. For Granules India Stock Analysis, the key point is that today’s share price fall occurred against a mid-pack valuation and return profile within the peer set.

Why Investors Are Watching Granules India

• Granules India Share Price fell 2.28% today to Rs 855.50.
• The stock closed Rs 19.95 below its previous close of Rs 875.45.
• Day’s open, high and low were Rs 875, Rs 878.60 and Rs 855.50.
• Market capitalisation stood at Rs 23,868.23 crore, and turnover was Rs 5.4 crore.
• Key valuation metrics include P/E of 36.05, P/B of 4.87, ROE of 14.13%, ROCE of 15.74%, EPS of Rs 24.28 and book value of Rs 179.7.

About Granules India

Granules India operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company within that classification and shows it as a listed stock on NSE and BSE. For readers following Granules India Stock News, the available profile information supports a basic company-context view alongside the price data. Univest uses this section to keep the article factual and tied to the supplied company classification, while the rest of the piece focuses on Granules India Share Price, valuation and peer context.

Track Granules India Share Price on Univest

Use Granules India (GRANULES) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Investors can track Granules India Share Price on Univest for live price updates, company ratios, market capitalisation, shareholding pattern, 52-week levels and market insights. Univest also brings together Granules India Share Price Today, Granules India Stock News and Granules India Share Price update coverage in one place, helping readers review the stock’s latest movement with the company’s fundamentals and sector context.

Conclusion: Granules India Share Price fell 2.28% today to Rs 855.50, and the latest Granules India Share Price Today update shows a stock that should be read through its valuation, sector benchmark and peer comparison rather than an unverified reason. For Granules India Stock News readers, the important takeaways are the exact price move, the Rs 23,868.23 crore market cap, and the company’s current place versus healthcare peers. Univest will continue to track Granules India Share Price, Granules India Share Price news and Granules India Share Price fall as new verified data arrives.

Frequently Asked Questions

Why did Granules India Share Price fall today?

Ans.  The supplied data confirms a 2.28% decline in Granules India Share Price to Rs 855.50, but it does not establish a company-specific catalyst. The session data only verifies price action, turnover and valuation context.

What was Granules India Share Price Today?

Ans.  Granules India Share Price Today closed at Rs 855.50, down Rs 19.95 from the previous close of Rs 875.45. The stock opened at Rs 875 and touched an intraday high of Rs 878.60.

What was the market capitalisation of Granules India?

Ans.  Granules India’s market capitalisation stood at Rs 23,868.23 crore. The company is tagged as a Large Cap in the supplied data, which provides size context for Granules India Share Price and peer comparison.

How do Granules India valuation metrics look?

Ans.  Granules India trades at a P/E of 36.05 and a P/B of 4.87. EPS is Rs 24.28 and book value is Rs 179.7 per share, while dividend yield is 0.2%.

How does Granules India compare with healthcare peers?

Ans.  Compared with peers, Granules India’s P/E of 36.05 is below Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs, but above Zydus Lifesciences and Cipla. Its ROE and ROCE sit in the middle of the group.

What do Granules India financial ratios show?

Ans.  The company’s ROE is 14.13% and ROCE is 15.74%, while EPS is Rs 24.28 and book value is Rs 179.7. These figures provide context for Granules India Fundamental Analysis and current valuation.

What was the day’s price range in Granules India Share Price?

Ans.  Granules India traded between Rs 855.50 and Rs 878.60 today. The close was at the day’s low, which makes the price action relevant for readers following Granules India Share Price news and stock updates.